Mico BioMed Co. Ltd. - Asset Resilience Ratio
Mico BioMed Co. Ltd. (214610) has an Asset Resilience Ratio of 0.30% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 214610 current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Mico BioMed Co. Ltd.'s Asset Resilience Ratio has changed over time. See Mico BioMed Co. Ltd. (214610) shareholders funds for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Mico BioMed Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 214610 stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩100.00 Million | 0.3% |
| Total Liquid Assets | ₩100.00 Million | 0.30% |
Asset Resilience Insights
- Limited Liquidity: Mico BioMed Co. Ltd. maintains only 0.30% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Mico BioMed Co. Ltd. Industry Peers by Asset Resilience Ratio
Compare Mico BioMed Co. Ltd.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
China Science Publishing & Media Ltd
SHG:601858 |
Publishing | 19.10% |
|
China Publishing & Media Hldg
SHG:601949 |
Publishing | 16.58% |
|
Tangel Publishing
SHE:300148 |
Publishing | 27.22% |
|
Muza S.A
WAR:MZA |
Publishing | 5.78% |
|
Gyldendal A/S
CO:GYLD-B |
Publishing | 0.00% |
|
Aspermont Ltd
AU:ASP |
Publishing | 19.23% |
|
Roularta
BR:ROU |
Publishing | 0.13% |
|
Yellow Pages Limited
TO:Y |
Publishing | 1.53% |
Annual Asset Resilience Ratio for Mico BioMed Co. Ltd. (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Mico BioMed Co. Ltd..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 25.29% | ₩13.77 Billion ≈ $9.33 Million |
₩54.47 Billion ≈ $36.91 Million |
-11.63pp |
| 2023-12-31 | 36.92% | ₩22.64 Billion ≈ $15.34 Million |
₩61.32 Billion ≈ $41.55 Million |
+12.10pp |
| 2022-12-31 | 24.82% | ₩14.28 Billion ≈ $9.68 Million |
₩57.51 Billion ≈ $38.97 Million |
-16.75pp |
| 2021-12-31 | 41.58% | ₩36.87 Billion ≈ $24.99 Million |
₩88.68 Billion ≈ $60.10 Million |
+7.57pp |
| 2020-12-31 | 34.01% | ₩24.13 Billion ≈ $16.35 Million |
₩70.96 Billion ≈ $48.09 Million |
-5.10pp |
| 2019-12-31 | 39.10% | ₩9.79 Billion ≈ $6.63 Million |
₩25.03 Billion ≈ $16.96 Million |
+8.67pp |
| 2018-12-31 | 30.44% | ₩7.35 Billion ≈ $4.98 Million |
₩24.16 Billion ≈ $16.37 Million |
+10.24pp |
| 2017-12-31 | 20.20% | ₩3.32 Billion ≈ $2.25 Million |
₩16.44 Billion ≈ $11.14 Million |
+3.15pp |
| 2016-12-31 | 17.05% | ₩1.62 Billion ≈ $1.10 Million |
₩9.48 Billion ≈ $6.42 Million |
-- |
About Mico BioMed Co. Ltd.
RollingStone Co., Ltd. provides point-of-care-testing diagnostic systems based on Lab-on-a-Chip technology. The company offers molecular diagnostics devices comprising Veri-Q PREP M16 (G2-16TU) system, a device that include membrane to extract nucleic acid using tube; VERI-Q PCR 316, a device to get the result in a short time using plastic chip; VERI-Q PCR 204 (G2-4), a device to deliver the real… Read more